Ignite Creation Date:
2024-05-06 @ 12:57 AM
Last Modification Date:
2024-10-26 @ 10:57 AM
Study NCT ID:
NCT01697319
Status:
TERMINATED
Last Update Posted:
2016-01-12
First Post:
2012-09-17
Brief Title:
Efficacy and Safety Study of BMN 110 for Morquio A Syndrome Patients Who Have Limited Ambulation
Sponsor:
BioMarin Pharmaceutical
Organization:
BioMarin Pharmaceutical
Conditions & Keywords Data
Conditions:
| Name |
|---|
| MPS IVA |
| Mucopolysaccharidosis IVA |
| Morquio A Syndrome |
Keywords:
| Name | View |
|---|---|
| Grip Pinch | View |
| Mucopolysaccharidosis IVA Type A | View |
| MPS IVA Type A | View |
| Mucopolysaccharidosis IVA | View |
| MPS IVA | View |
| Morquio A Syndrome | View |
| Lysosomal Storage Disorder | View |
| LSD | View |
| N-acetylgalactosamine-6-sulfatase | View |
| N-acetylgalactosamine-6-sulfate | View |
| sulfatase | View |
| galactose-6-sulfatase | View |
| GALNS | View |
| enzyme replacement therapy | View |
| ERT | View |
| MOR-006 | View |
| CPET | View |
| Limited ambulation | View |